| Farrell O Mendelsohn, MD | |
|
801 Princeton Ave Sw, Sute 706, Birmingham, AL 35211-1310 | |
| (205) 780-4330 | |
| (205) 780-7775 |
| Full Name | Farrell O Mendelsohn |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 32 Years |
| Location | 801 Princeton Ave Sw, Birmingham, Alabama |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1770548307 | NPI | - | NPPES |
| 000077820 | Medicaid | AL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 21745 (Alabama) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Princeton Baptist Medical Center | Birmingham, AL | Hospital |
| Grandview Medical Center | Birmingham, AL | Hospital |
| Walker Baptist Medical Center | Jasper, AL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cardiology P C | 6204723752 | 6 |
News Archive
Bluegrass Vascular Technologies, a medical technology company focused on life-saving devices and methods for vascular access procedures, has announced patient enrollment in the first clinical study of its Surfacer Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel "inside-out" approach to gain venous access.
How is your sense of smell? Do you find yourself frequently dozing off during the day or thrashing about during dreams? Often, early stage Parkinson's disease does not present with typical motor disturbance symptoms, making diagnosis problematic.
Results of the International Nuclear Workers Study suggest a linear increase in incidence of solid cancers with increasing exposure to radiation.
At a press conference in Washington Wednesday, "10 governors said they had already cut millions from their budgets since the recession hit at the end of 2007, and that if the funds were not approved in coming weeks they would have to slash funding for services like hospice care or preschool programs," Reuters reports.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
› Verified 3 days ago
| Entity Name | Cardiology P C |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285690776 PECOS PAC ID: 6204723752 Enrollment ID: O20040301000736 |
News Archive
Bluegrass Vascular Technologies, a medical technology company focused on life-saving devices and methods for vascular access procedures, has announced patient enrollment in the first clinical study of its Surfacer Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel "inside-out" approach to gain venous access.
How is your sense of smell? Do you find yourself frequently dozing off during the day or thrashing about during dreams? Often, early stage Parkinson's disease does not present with typical motor disturbance symptoms, making diagnosis problematic.
Results of the International Nuclear Workers Study suggest a linear increase in incidence of solid cancers with increasing exposure to radiation.
At a press conference in Washington Wednesday, "10 governors said they had already cut millions from their budgets since the recession hit at the end of 2007, and that if the funds were not approved in coming weeks they would have to slash funding for services like hospice care or preschool programs," Reuters reports.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Farrell O Mendelsohn, MD 801 Princeton Ave Sw, Ste 707, Birmingham, AL 35211-1310 Ph: (205) 780-4330 | Farrell O Mendelsohn, MD 801 Princeton Ave Sw, Sute 706, Birmingham, AL 35211-1310 Ph: (205) 780-4330 |
News Archive
Bluegrass Vascular Technologies, a medical technology company focused on life-saving devices and methods for vascular access procedures, has announced patient enrollment in the first clinical study of its Surfacer Inside-Out Access Catheter System, a proprietary system that allows physicians to perform a novel "inside-out" approach to gain venous access.
How is your sense of smell? Do you find yourself frequently dozing off during the day or thrashing about during dreams? Often, early stage Parkinson's disease does not present with typical motor disturbance symptoms, making diagnosis problematic.
Results of the International Nuclear Workers Study suggest a linear increase in incidence of solid cancers with increasing exposure to radiation.
At a press conference in Washington Wednesday, "10 governors said they had already cut millions from their budgets since the recession hit at the end of 2007, and that if the funds were not approved in coming weeks they would have to slash funding for services like hospice care or preschool programs," Reuters reports.
PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat acute cardiovascular disorders and infectious diseases, has received a Phase 2 grant in the amount of $986,000 from the National Institute of Health (NIH) to support the development of defensin mimetic antimicrobial compounds for the treatment of oral candidiasis. This grant will fund this research project through August 31, 2012. This award represents the 14th grant or research contract received to date by PolyMedix.
› Verified 3 days ago
Juan Mario Bernal, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |